Marinus Pharmaceuticals, Inc. (MRNS)

NASDAQ: MRNS · IEX Real-Time Price · USD

1.430

+0.040 (2.88%)

At close: Jul 19, 2024, 4:00 PM

1.320

-0.110 (-7.69%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Marinus Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2012
Revenue	28.29	30.99	25.48	15.35	1.72	0	Upgrade
Revenue Growth (YoY)	30.53%	21.63%	66.03%	793.19%	-	-	Upgrade
Cost of Revenue	2.48	1.93	0.34	1.48	0	0	Upgrade
Gross Profit	25.8	29.06	25.14	13.87	1.72	0	Upgrade
Selling, General & Admin	64.57	61.15	56.85	37.28	18.55	11.46	Upgrade
Research & Development	95.57	99.39	79.91	73.52	51.11	42.97	Upgrade
Other Operating Expenses	0	0	1.17	0	0	0.05	Upgrade
Operating Expenses	160.15	160.54	137.93	110.8	69.66	54.48	Upgrade
Operating Income	-134.34	-131.49	-112.79	-96.93	-67.94	-54.48	Upgrade
Interest Expense / Income	17.09	16.9	10.67	2.58	0	0	Upgrade
Other Expense / Income	-4.56	-5.44	-107.03	-0.74	-0.46	-0.35	Upgrade
Pretax Income	-146.88	-142.94	-16.43	-98.78	-67.48	-54.12	Upgrade
Income Tax	-1.54	-1.54	3.39	0	0	0	Upgrade
Net Income	-145.34	-141.41	-19.82	-98.78	-67.48	-54.12	Upgrade
Preferred Dividends	0	0	0	0	8.88	0	Upgrade
Net Income Common	-145.34	-141.41	-19.82	-98.78	-76.36	-54.12	Upgrade
Shares Outstanding (Basic)	57	54	39	37	27	14	Upgrade
Shares Outstanding (Diluted)	57	54	39	37	27	14	Upgrade
Shares Change	9.82%	37.56%	6.47%	34.57%	100.10%	33.30%	Upgrade
EPS (Basic)	-2.64	-2.63	-0.51	-2.69	-2.80	-3.97	Upgrade
EPS (Diluted)	-2.64	-2.63	-0.51	-2.69	-2.80	-3.97	Upgrade
Free Cash Flow	-114.09	-118.11	-114.49	-58.37	-60.91	-49.02	Upgrade
Free Cash Flow Per Share	-2.01	-2.20	-2.93	-1.59	-2.23	-3.60	Upgrade
Gross Margin	91.22%	93.76%	98.67%	90.37%	100.00%	-	Upgrade
Operating Margin	-474.91%	-424.30%	-442.69%	-631.68%	-3954.42%	-	Upgrade
Profit Margin	-513.80%	-456.31%	-77.78%	-643.70%	-4444.41%	-	Upgrade
Free Cash Flow Margin	-403.33%	-381.14%	-449.36%	-380.36%	-3545.52%	-	Upgrade
EBITDA	-129.08	-125.31	-5.09	-95.53	-66.88	-53.62	Upgrade
EBITDA Margin	-456.31%	-404.37%	-19.96%	-622.53%	-3892.72%	-	Upgrade
Depreciation & Amortization	0.71	0.74	0.67	0.67	0.6	0.5	Upgrade
EBIT	-129.79	-126.05	-5.76	-96.19	-67.48	-54.12	Upgrade
EBIT Margin	-458.81%	-406.75%	-22.59%	-626.88%	-3927.53%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).